Hank C. K. Wuh, MD, MPH – Chairman
Dr. Wuh is a co-founder of TruTag Technologies and the founder and CEO of SKAI Ventures, a global venture accelerator focused on transforming ingenious ideas into disruptive technologies and high growth companies. The motto at SKAI Ventures: Invent. Disrupt. Inspire. A surgeon, inventor, and entrepreneur, Dr. Wuh has led the development of over twenty biomedical and consumer healthcare innovations from concept to commercialization. Dr. Wuh is also the founder of Eyegenix, LLC, which is developing an artificial cornea for transplantation to treat blindness. At the University of Hawaii, Dr. Wuh is a member of the President’s Advisory Council on Innovation and Technology Advancement, Dean’s Council at the School of Engineering, and is Associate Clinical Professor of Surgery at the John A. Burns School of Medicine. Dr. Wuh holds a Bachelor’s degree in Human Biology from Johns Hopkins University, a Masters of Public Health from Harvard University, a Medical Doctorate from Johns Hopkins University School of Medicine, and was Chief Resident in Orthopedic Surgery at Stanford Medical Center.
Michael Bartholomeusz, MS, PhD – Chief Executive Officer
Dr. Bartholomeusz brings more than 20 years of experience leading, building, operating and investing in emerging technology and advanced materials companies. Prior to joining TruTag, he served as CEO and as a member of the Board of Directors for HZO, Inc., a leader in thin film protection from liquids for electronics, overseeing the expansion and development of the company from pre-revenue to high-growth. From 2008 to 2012, Dr. Bartholomeusz served as CEO and co-founder of AQT Solar, a leading producer of thin film solar cell renewable energy products, taking the company from seed-stage to commercialization in less than three years. Dr. Bartholomeusz has extensive experience doing business in Asia where he green-fielded multiple successful joint ventures in China. He has over 25 granted and pending patents and currently sits on the Board of SunEdison Semiconductor (Nasdaq: SEMI) and on the advisory boards of privately-held Cubergand Quantpower. Dr. Bartholomeusz holds a Bachelor’s degree in Physics from the University of California, Santa Cruz, and a M.S. and PhD in Materials Engineering from the University of Virginia.
Kent Mansfield – President
Mr. Mansfield has worked as an executive for leading private and public technology companies in the brand protection and software markets. He has served as Senior Vice President of UK‐based Smart Holograms Ltd., a brand and product protection company, as co-founder and President of Boardroom Software, Inc., and as Chief Operating Officer of B&B ARMR, Inc. (a division of Integrated Security Systems, Inc.), a physical security hardware manufacturer. As an early innovator in the industry, Mr. Mansfield served as Chief Operating Officer of Authentix, Inc., a brand protection and product authentication company, helping build this nanotechnology company into one of the early success stories in the brand protection market. Authentix was later acquired by the Carlyle Group and JH Whitney. He was also Managing Director at Ultrak, Inc., a publicly traded security hardware provider, where he was responsible for the company’s European operation based in Antwerp, Belgium prior to its sale to Honeywell. Mr. Mansfield holds two patents in business software. He earned his degree from Texas Tech University.
Michael O’Neill, PhD – Chief Science Officer
Dr. O’Neill has over 25 years of technology development experience and was previously Senior Vice President and co-founder of Calimetrics, an optical data storage start-up that commercialized technology he co-invented. After Calimetrics was sold to LSI Logic (now LSI Corporation) in 2004, he worked as Special Advisor to 20th Century Fox on technical and security issues related to the emerging high-definition DVD formats, including the development of renewable security features for Blu-Ray. He also worked on a number of significant research and development for SKAI Ventures portfolio projects prior to co-founding TruTag Technologies. Dr. O’Neill is a veteran of the U.S. Navy submarine corps in the field of radiological health and safety. He is well-published and holds over 15 U.S. and foreign patents in laser metrology, optical data storage, and product security. Dr. O’Neill earned a PhD in Biophysics from the University of California, Berkeley.
Peter M. O. Wong, JD – Chief Operating Officer
Mr. Wong’s career has focused on providing strategic guidance to technology companies at critical inflection points. Prior to co-founding TruTag Technologies, he served as Senior Vice President and General Counsel for educational technology developer LeapFrog Enterprises, Inc., where he helped the company prepare for and complete its successful initial public offering (2002 IPO of the Year – $135 million), expand internationally, and complete many significant IP transactions. Prior to that, Mr. Wong was Associate General Counsel and Vice President of Corporate Development at Quokka Sports, Inc., a digital media company, joining prior to its IPO and handling multiple acquisitions and financings. Mr. Wong was previously a business attorney at the Cooley LLP and Howard, Rice (now Arnold & Porter LLP) law firms in San Francisco, where he focused on corporate transactions such as VC financings, M&A, and public offerings. Mr. Wong earned his undergraduate degree from the University of California, Berkeley and his J.D. from the University of California, Hastings College of Law.
Hod Finkelstein, MBA, PhD – Chief Technology Officer
Dr. Finkelstein has over twenty years of technology development, manufacturing and operations experience. Prior to joining TruTag Technologies, he was Director of Technology Development for Illumina, Inc., a leading genomic analysis and DNA sequencing company, where he led the development and productization of advanced sequencing products and technologies. Prior to that, he was co-founder and Chief Technology Officer for Vitasense Technologies, Inc., a developer of non-invasive tissue monitors, and Vice President of Operations for RF Magic, a developer of radio frequency integrated circuits for consumer electronics applications that was later acquired by Entropic Communications. Previously, Dr. Finkelstein held technical and business leadership positions at Mellanox Technologies, Inc., Chartered Semiconductor Manufacturing (since acquired by Globalfoundries) and Intel Corporation. He earned his B.S. in Electrical Engineering from Cornell University, a M.S. in Electrical Engineering from Technion – Israel Institute of Technology, a MBA from Kellogg Graduate School of Management and Recanati Graduate School of Business Administration, and a Ph.D. in Electrical and Computer Engineering from the University of California, San Diego.
Craig Leidholm, MS – Senior Vice President, Materials Manufacturing
Mr. Leidholm is a technology executive with a proven track record of developing advanced materials from concept to production. Prior to joining TruTag Technologies, he was Vice President of Engineering and Technology at Solexant Corporation, a high-tech photo-voltaic company, where he led technology development and manufacturing. Prior to that, he was Director of Process Engineering at NanoSolar, Inc., another advanced photo-voltaic company, where he was the founding technology executive and led the transfer of IP from research and development to production scale-up. Previously, Mr. Leidholm led engineering efforts at Microfabrica, Inc., NuTool, Inc. and International Solar Electric Technology, Inc.; and was a co-founder of Laboratory Catalyst Systems, a developer of technology for catalyst discovery and development. He is co-author of eight issued patents as well as numerous other patent applications and technical publications in the area of solar cell materials, processes and equipment. He earned his B.S. in Electrical Engineering and M.S. in Materials Science from the University of Southern California.
Barry McDonogh – Vice President, Business Development
As Vice President of Business Development, Mr. McDonogh is responsible for the identification and development of key commercial opportunities and strategic initiatives that expand TruTagTechnologies’ products and services into new markets. Prior to his current role, he served as Vice President, Business Development and Corporate Strategy at Systech International, a serialization, product safety, anti-counterfeiting and brand protection company, where he led the development of Systech’sglobal partnership program to scale its operations internationally. Prior to Systech, he served as the Director of Corporate Development at UDG Healthcare plc, an international provider of clinical, commercial, communication and packaging services to the healthcare industry where he drove the commercial development of United Drug subsidiaries in North America. Mr. McDonogh has a B.S. from University College Dublin and a MBA from University College Dublin’s Smurfit Graduate School of Business.